Lejeune v. Louisiana Medical Mutual Insurance Co.

153 So. 3d 1021, 13 La.App. 3 Cir. 845, 2014 WL 550927, 2014 La. App. LEXIS 328
CourtLouisiana Court of Appeal
DecidedFebruary 12, 2014
DocketNo. CA 13-845
StatusPublished
Cited by3 cases

This text of 153 So. 3d 1021 (Lejeune v. Louisiana Medical Mutual Insurance Co.) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lejeune v. Louisiana Medical Mutual Insurance Co., 153 So. 3d 1021, 13 La.App. 3 Cir. 845, 2014 WL 550927, 2014 La. App. LEXIS 328 (La. Ct. App. 2014).

Opinion

CONERY, Judge.

¡ iJanie Lejeune appeals a trial court’s grant of summary judgment in favor of Dr. Thad Bourque and Louisiana Medical Mutual Insurance Company. Mrs. Lejeune filed suit against Dr. Bourque for medical malpractice alleging that Dr. Bourque breached the standard of care in his treatment of her deceased husband, Joseph Le-jeune. Defendants moved for summary judgment and filed an affidavit containing the opinion of the medical review panel stating that Dr. Bourque’s treatment of Mr. Lejeune was appropriate and that he did not breach the standard of care for a urologist. The trial court found that Mrs. Lejeune failed to offer proper expert testimony to controvert the expert opinion of the medical review panel (MRP) and granted summary judgment dismissing her claim with prejudice at her cost. For the following reasons, we affirm.

FACTS

After seeking treatment for blood in his urine with Dr. Kent Humble, Mr. Lejeune was referred to Dr. Thad Bourque, a urologist. Dr. Bourque first saw Mr. Lejeune on August 28, 2008. Dr. Bourque ordered testing, and a CT scan revealed a seven centimeter mass on Mr. Lejeune’s right kidney that appeared to affect the fatty tissue on the edge of the kidney capsule itself. On September 17, 2008, a right radical nephrectomy was performed, removing the kidney and the surrounding fat tissue. Mr. Lejeune was discharged from the hospital on September 21, 2008, and seen in Dr. Bourque’s office for a post-surgical visit on September 25, 2008.

At the September 25, 2008 office visit, Dr. Bourque observed that Mr. Lejeune’s liver enzymes normalized after surgery. The surgical pathology report dated September 18, 2008, indicated that the “MARGINS OF EXCISION FREE EOF TUMOR.” Dr. Bourque further noted that Mr. Lejeune had an increased risk of recurrence of cancer since the tumor was Grade 4 and had extended into the fatty tissue on the edge of the kidney capsule. In his deposition testimony, Dr. Bourque discussed the implications of Mr. Le-jeune’s increased risk of cancer in relation to the surgery he had just performed removing Mr. Lejeune’s right kidney and the fatty tissue surrounding it. First, he did not obtain an oncology consult after the surgery “because, typically they do not give chemotherapy without the presence of visible residual disease, either local or metastatic.” Second, when questioned if he presumed all the cancer cells had been removed with the surgical procedure, Dr. Bourque responded, “[Slaying that I got all the cancer is not something that anybody can say.” Dr. Bourque also testified that removing the tumor and finding it did not “go to or through the margins” lead him to believe “the local tumor was resect-ed completely,” and no other cancerous lesions were detected elsewhere in Mr. Lejeune at that time. The pathology report confirmed his opinion. Due, however, [1023]*1023to the increased risk of recurrence of the cancer, Dr. Bourque wanted to follow Mr. Lejeune quarterly and continue to conduct testing which included a chest x-ray, CMP, and CBC.1

Mr. Lejeune returned for a follow-up visit with Dr. Bourque on October 30, 2008. Dr. Bourque ordered and reviewed the recommended series of testing on Mr. Lejeune. The testing revealed the following as per Dr. Bourque’s testimony, “[t]he chest x-ray didn’t show any signs of recurrence. His CBC showed normal white blood count and hemoglobin levels with no acute infection.” There was no |3mention in Dr. Bourque’s deposition testimony about the CMP results. By the time of this visit, Mr. Lejeune had started to gain weight. Dr. Bourque once again noted that Mr. Lejeune had a high grade tumor removed and was to be watched closely for possible recurrence. Dr. Bourque’s notes indicated that Mr. Lejeune should return in three months and he scheduled a followup appointment for him on January 22, 2009.

Dr. Bourque’s office notes indicate that in the interim, Mr. Lejeune came to his satellite office in Opelousas on the morning of December 8, 2008, asking to see Dr. Bourque because he was concerned that his cancer may have returned due to the fact that he was experiencing swelling again. Mr. Lejeune asked whether there was a blood test Dr. Bourque could order to check the problem. Dr. Bourque was not in the Opelousas office on December 8, 2008, but was consulted by phone about the request by his nurse, Nancy Major. After speaking with Dr. Bourque, Nurse Major called Mr. Lejeune and relayed Dr. Bourque’s advice that Mr. Lejeune should see his family physician, Dr: Mark Dawson, who could address the problem. Mr. Lejeune was already scheduled for followup testing on January 22, 2009, with Dr. Bourque. The documentation of the conversation indicates that Mr. Lejeune responded that he would call Dr. Dawson to schedule an appointment in the morning. The medical records contained in the record on appeal do not contain any documentation that Mr. Lejeune did follow-up with Dr. Dawson.

Mr. Lejeune returned to see Dr. Bo-urque for his regularly scheduled appointment on January 22, 2009. Dr. Bourque noted that Mr. Lejeune’s weight was stable and that he would watch Mr. Lejeune closely for possible recurrence of the high grade tumor. The same testing was ordered and reviewed by Dr. Bourque. The chest x-ray was negative or normal. The CBC showed no signs of infection Land his blood counts were a little lower than the time before. His CMP, or metabolic panel, showed a high blood sugar level and his overall kidney function was a bit elevated, which was not unexpected due to his age (seventy-four) and his having only one kidney.

Dr. Bourque wanted to see Mr. Lejeune in three months, as indicated on his office summary of the January 22, 2009 visit. For some unknown reason, the appointment was scheduled for six months later. Dr. Bourque testified in his deposition that he had wanted to see Mr. Lejeune every three months and could not explain why an appointment was scheduled for July 28, 2009. Dr. Bourque offered that it might be possible that he wrote six months on the charge ticket, or that the scheduling person scheduled it for six months instead of three.

[1024]*1024Mr. Lejeune did not return for treatment with Dr. Bourque, but continued to treat with his family physician, Dr. Dawson. He presented to Dr. Dawson on three occasions in June 2009 — 6/17, 6/23, and 6/30. On each of these office visits he complained of a cough and a shortness of breath. A chest x-ray on June 18, 2009 revealed bilateral pneumonia with car-diomegaly, an enlarged heart. The chest x-ray of June 30, 2009, revealed a suspicious white spot on the left, pleural effusion on the right and cardiomegaly. The Brain Natriuretic Peptide (BNP) was normal, indicating no heart failure and there was no increase in his white blood cell count. Dr. Dawson noted no acute distress or respiratory distress, and his assessment was DOE (dyspnea, or shortness of breath on exertion), with abnormal chest x-ray. Dr. Dawson then ordered a repeat chest x-ray with a PA view, in which the x-ray beams pass from back to front.

On July 1, 2009, Mr. Lejeune’s condition worsened and at the request of Dr. Dawson he presented to the emergency room for possible pneumonia versus Rpleural effusion. Dr. Dawson also recommended a pulmonologist consult. Mr. Lejeune was subsequently admitted to Our Lady of Lourdes Regional Medical Center. After extensive testing, an oncologist, Dr. Joseph E. Brierre, was consulted and on July 2, 2009, Dr. Brierre diagnosed Mr. Lejeune with metastatic lung disease related to his previously diagnosed renal cell carcinoma. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Thomas v. Drew
240 So. 3d 980 (Louisiana Court of Appeal, 2018)
Justin Thomas v. Otis Rashad Drew, M.D.
Louisiana Court of Appeal, 2018
Kinch v. Our Lady of Lourdes Regional Medical Center
181 So. 3d 900 (Louisiana Court of Appeal, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
153 So. 3d 1021, 13 La.App. 3 Cir. 845, 2014 WL 550927, 2014 La. App. LEXIS 328, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lejeune-v-louisiana-medical-mutual-insurance-co-lactapp-2014.